Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Bowlus

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Alimentary Pharmacology & Therapeutics|April 15, 2025
Editorial: When and What to Ask-Capturing the Symptoms Experienced by Patients With PSCChristopher L Bowlus, Donna M Evon
Clinics in Liver Disease|October 21, 2022
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line TherapiesChung-Heng Liu, Christopher L Bowlus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2023
Recent Advances in the Management of Primary Sclerosing CholangitisDavid N Assis, Christopher L Bowlus
Clinics in Liver Disease|November 9, 2023
Autoimmune Markers in Primary Biliary CholangitisShivani K Shah, Christopher L Bowlus
Gastroenterology|May 15, 2003
Discussion of the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac diseaseChristopher L Bowlus, Benedicte A Lie
Liver Research|July 7, 2018
Primary sclerosing cholangitis: A review and updateJames H Tabibian, Christopher L Bowlus
Current Opinion in Gastroenterology|January 31, 2016
Management of symptom complexes in primary biliary cholangitisAlexander Kuo, Alexander Kuo, Christopher L Bowlus
Pharmacology & Toxicology|May 20, 2003
Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cellsJonas Tallkvist, Christopher L Bowlus, Bo Lönnerdal
Gastroenterology & Hepatology|April 19, 2021
Statins, Fibrates, and Other Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Cholestatic Liver DiseasesAlanna M K Dubrovsky, Christopher L Bowlus
Journal of Hepatology|August 17, 2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|April 15, 2025
Editorial: When and What to Ask-Capturing the Symptoms Experienced by Patients With PSCChristopher L Bowlus, Donna M Evon
Clinics in Liver Disease|October 21, 2022
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line TherapiesChung-Heng Liu, Christopher L Bowlus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2023
Recent Advances in the Management of Primary Sclerosing CholangitisDavid N Assis, Christopher L Bowlus
Clinics in Liver Disease|November 9, 2023
Autoimmune Markers in Primary Biliary CholangitisShivani K Shah, Christopher L Bowlus
Gastroenterology|May 15, 2003
Discussion of the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac diseaseChristopher L Bowlus, Benedicte A Lie
Liver Research|July 7, 2018
Primary sclerosing cholangitis: A review and updateJames H Tabibian, Christopher L Bowlus
Current Opinion in Gastroenterology|January 31, 2016
Management of symptom complexes in primary biliary cholangitisAlexander Kuo, Alexander Kuo, Christopher L Bowlus
Pharmacology & Toxicology|May 20, 2003
Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cellsJonas Tallkvist, Christopher L Bowlus, Bo Lönnerdal
Gastroenterology & Hepatology|April 19, 2021
Statins, Fibrates, and Other Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Cholestatic Liver DiseasesAlanna M K Dubrovsky, Christopher L Bowlus
Journal of Hepatology|August 17, 2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield
Pageof 19